These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
666 related items for PubMed ID: 16880683
1. Comparative effects of alendronate and alfacalcidol on cancellous and cortical bone mass and bone mechanical properties in ovariectomized rats. Iwamoto J, Seki A, Takeda T, Sato Y, Yamada H, Yeh JK. Exp Anim; 2006 Jul; 55(4):357-67. PubMed ID: 16880683 [Abstract] [Full Text] [Related]
2. Comparative therapeutic effects of alendronate and alfacalcidol on cancellous and cortical bone mass and mechanical properties in ovariectomized osteopenic rats. Iwamoto J, Seki A, Takeda T, Sato Y, Yamada H, Yeh JK. J Nutr Sci Vitaminol (Tokyo); 2006 Feb; 52(1):1-8. PubMed ID: 16637224 [Abstract] [Full Text] [Related]
3. Therapeutic effect of risedronate on cancellous and cortical bone in ovariectomized osteopenic rats: a comparison with the effects of alfacalcidol. Iwamoto J, Seki A, Takeda T, Sato Y, Yamada H, Yeh JK. Exp Anim; 2006 Jul; 55(4):333-42. PubMed ID: 16880680 [Abstract] [Full Text] [Related]
4. Effect of risedronate on the cortical and cancellous bone mass and mechanical properties in ovariectomized rats: a comparison with the effects of alfacalcidol. Iwamoto J, Seki A, Takeda T, Sato Y, Yamada H, Yeh JK. J Nutr Sci Vitaminol (Tokyo); 2006 Dec; 52(6):393-401. PubMed ID: 17330501 [Abstract] [Full Text] [Related]
5. Effects of combined administration of alfacalcidol and risedronate on cancellous and cortical bone mass of the tibia in glucocorticoid-treated young rats. Iwamoto J, Seki A, Takeda T, Yamada H, Sato Y, Yeh JK. Chin J Physiol; 2008 Jun 30; 51(3):121-8. PubMed ID: 18935906 [Abstract] [Full Text] [Related]
6. Effects of alfacalcidol on cancellous and cortical bone mass in rats treated with glucocorticoid: a bone histomorphometry study. Iwamoto J, Seki A, Takeda T, Yamada H, Sato Y, Yeh JK. J Nutr Sci Vitaminol (Tokyo); 2007 Jun 30; 53(3):191-7. PubMed ID: 17874822 [Abstract] [Full Text] [Related]
7. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat. Smith BJ, Bu SY, Wang Y, Rendina E, Lim YF, Marlow D, Clarke SL, Cullen DM, Lucas EA. Bone; 2014 Jan 30; 58():151-9. PubMed ID: 24125756 [Abstract] [Full Text] [Related]
8. Comparable effects of alendronate and strontium ranelate on femur in ovariectomized rats. Chen B, Li Y, Yang X, Xie D. Calcif Tissue Int; 2013 Nov 30; 93(5):481-6. PubMed ID: 23897224 [Abstract] [Full Text] [Related]
9. Progressive increases in bone mass and bone strength in an ovariectomized rat model of osteoporosis after 26 weeks of treatment with a sclerostin antibody. Li X, Niu QT, Warmington KS, Asuncion FJ, Dwyer D, Grisanti M, Han CY, Stolina M, Eschenberg MJ, Kostenuik PJ, Simonet WS, Ominsky MS, Ke HZ. Endocrinology; 2014 Dec 30; 155(12):4785-97. PubMed ID: 25259718 [Abstract] [Full Text] [Related]
10. Effect of combined teriparatide and monthly minodronic acid therapy on cancellous bone mass in ovariectomized rats: a bone histomorphometry study. Iwamoto J, Seki A, Sato Y. Bone; 2014 Jul 30; 64():88-94. PubMed ID: 24727162 [Abstract] [Full Text] [Related]
11. Effects of alendronate and strontium ranelate on cancellous and cortical bone mass in glucocorticoid-treated adult rats. Sun P, Cai DH, Li QN, Chen H, Deng WM, He L, Yang L. Calcif Tissue Int; 2010 Jun 30; 86(6):495-501. PubMed ID: 20390406 [Abstract] [Full Text] [Related]
12. Differential maintenance of cortical and cancellous bone strength following discontinuation of bone-active agents. Shahnazari M, Yao W, Wang B, Panganiban B, Ritchie RO, Hagar Y, Lane NE. J Bone Miner Res; 2011 Mar 30; 26(3):569-81. PubMed ID: 20839286 [Abstract] [Full Text] [Related]
13. Beneficial effects of combined administration of alendronate and alfacalcidol on cancellous bone mass of the tibia in orchidectomized rats: a bone histomorphometry study. Iwamoto J, Takeda T, Matsumoto H, Sato Y, K Yeh J. J Nutr Sci Vitaminol (Tokyo); 2008 Feb 30; 54(1):11-7. PubMed ID: 18388402 [Abstract] [Full Text] [Related]
14. Combination treatment with eldecalcitol (ED-71) and raloxifene improves bone mechanical strength by suppressing bone turnover and increasing bone mineral density in ovariectomized rats. Takeda S, Sakai S, Shiraishi A, Koike N, Mihara M, Endo K. Bone; 2013 Mar 30; 53(1):167-73. PubMed ID: 23232307 [Abstract] [Full Text] [Related]
15. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH. Iwaniec UT, Samnegård E, Cullen DM, Kimmel DB. Bone; 2001 Oct 30; 29(4):352-60. PubMed ID: 11595618 [Abstract] [Full Text] [Related]
16. Effects of nicotine on bone and calciotropic hormones in aged ovariectomized rats. Iwaniec UT, Haynatzki GR, Fung YK, Akhter MP, Haven MC, Cullen DM. J Musculoskelet Neuronal Interact; 2002 Sep 30; 2(5):469-78. PubMed ID: 15758416 [Abstract] [Full Text] [Related]
17. Effects of combined treatment with eldecalcitol and alendronate on bone mass, mechanical properties, and bone histomorphometry in ovariectomized rats: a comparison with alfacalcidol and alendronate. Sugimoto M, Futaki N, Harada M, Kaku S. Bone; 2013 Jan 30; 52(1):181-8. PubMed ID: 23041510 [Abstract] [Full Text] [Related]
18. Effect of vitamin K2 and growth hormone on the long bones in hypophysectomized young rats: a bone histomorphometry study. Iwamoto J, Takeda T, Sato Y, Yeh JK. J Bone Miner Metab; 2007 Jan 30; 25(1):46-53. PubMed ID: 17187193 [Abstract] [Full Text] [Related]
19. Synergistic effect of vitamin K2 and prostaglandin E2 on cancellous bone mass in hypophysectomized young rats. Iwamoto J, Takeda T, Sato Y, Yeh JK. Calcif Tissue Int; 2006 Nov 30; 79(5):318-25. PubMed ID: 17048065 [Abstract] [Full Text] [Related]
20. Effects of alendronate and alfacalcidol on the femoral bone mass and bone strength in orchidectomized rats. Iwamoto J, Matsumoto H, Takeda T, Sato Y, Xu E, Yeh JK. Chin J Physiol; 2008 Dec 31; 51(6):331-7. PubMed ID: 19280876 [Abstract] [Full Text] [Related] Page: [Next] [New Search]